Ninh (Irene) La-Beck
Texas Tech University
H-index: 19
North America-United States
Top articles of Ninh (Irene) La-Beck
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Targeting immune checkpoint pathways in melanoma: triumphs and challenges | Patricia Ines Back Kaitlin Rascon Md Rakibul Islam Christopher Selby Ninh M La-Beck | 2023/7 | |
Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes | Pharmaceutics | Alberto Gabizon Hilary Shmeeda Benjamin Draper Ana Parente-Pereira John Maher | 2023/11/9 |
Pegylated Liposomal Alendronate Biodistribution, Immune Modulation, and Tumor Growth Inhibition in a Murine Melanoma Model | Biomolecules | Md Rakibul Islam Jalpa Patel Patricia Ines Back Hilary Shmeeda Raja Reddy Kallem | 2023/8/26 |
Abstract A42: Impact of liposomal drug delivery and alendronate co-encapsulation on the immune modulatory effects of doxorubicin in the tumor microenvironment | Cancer Immunology Research | Md Rakibul Islam Jalpa Patel Patricia Ines Back Hilary Shmeeda Konstantin Adamsky | 2022/12/1 |
Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a … | Nanotheranostics | Md Rakibul Islam Jalpa Patel Patricia Ines Back Hilary Shmeeda Konstantin Adamsky | 2022 |
Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment | Ninh M La-Beck Xinli Liu Hilary Shmeeda Claire Shudde Alberto A Gabizon | 2021/1/1 | |
Antibody-drug conjugates: an evolving approach for melanoma treatment | Trevor S Anderson Amanda L Wooster Ninh M La-Beck Dipongkor Saha Devin B Lowe | 2021/2/1 | |
Nanoparticle-induced complement activation: implications for cancer nanomedicine | Ninh M La-Beck Md Rakibul Islam Maciej M Markiewski | 2021/1/8 | |
Abstract B21: Dual immunotherapy targeting macrophages and PD-1 immune checkpoint for treatment of melanoma | Cancer Immunology Research | Claire E Shudde Jalpa Patel Robin Rajan Hilary Shmeeda Dung Nguyen | 2020/3 |
Optimizing Patient Outcomes with PD‐1/PD‐L1 Immune Checkpoint Inhibitors for the First‐Line Treatment of Advanced Non–Small Cell Lung Cancer | Ninh M La‐Beck Dung T Nguyen Alex D Le Saeed K Alzghari Saralinh T Trinh | 2020/3 | |
Translational considerations in nanomedicine: the oncology perspective | Alberto A Gabizon Rafael TM de Rosales Ninh M La-Beck | 2020/1/1 |
Co-Authors
